Comparison between ANG Lifesciences IPO and Manav infra projects IPO.
ANG Lifesciences IPO is a SME Fixed Price IPO proposed to list at BSE SME while Manav infra projects IPO is a SME Fixed Price proposed to list at NSE SME.
| ANG Lifesciences IPO | Manav infra projects IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Oneview Corporate Advisors Pvt.Ltd. | Navigant Corporate Advisors Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Guiness Securities Ltd. | Alacrity Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of ANG Lifesciences IPO is up to ₹11.39 Cr whereas the issue size of the Manav infra projects IPO is up to ₹5.23 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Manav infra projects IPO is ₹30.00 per share.
| ANG Lifesciences IPO | Manav infra projects IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹80.00 per share | ₹30.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 4000 shares |
| Fresh Issue Size | 14,24,000 shares | 17,44,000 shares |
| Fresh Issue Size (Amount) | up to ₹11.39 Cr | up to ₹5.23 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 14,24,000 shares | 17,44,000 shares |
| Issue Size Total (Amount) | up to ₹11.39 Cr | up to ₹5.23 Cr |
ANG Lifesciences IPO opens on Aug 29, 2017, while Manav infra projects IPO opens on Sep 04, 2017. The closing date of ANG Lifesciences IPO and Manav infra projects IPO is Aug 31, 2017, and Sep 08, 2017, respectively.
| ANG Lifesciences IPO | Manav infra projects IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 29, 2017 | Sep 04, 2017 |
| Issue Close | Aug 31, 2017 | Sep 08, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Sep 08, 2017 | Sep 18, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
ANG Lifesciences IPO P/E ratio is , as compared to Manav infra projects IPO P/E ratio of .
| ANG Lifesciences IPO | Manav infra projects IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹41.47 Cr. | ₹20.51 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the ANG Lifesciences IPO Retail Individual Investors (RII) are offered 7,12,000 shares while in Manav infra projects IPO retail investors are offered 7,12,000 shares. Qualified Institutional Buyers (QIB) are offered in ANG Lifesciences IPO and in Manav infra projects IPO.
| ANG Lifesciences IPO | Manav infra projects IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 76,800 shares | 92,000 shares |
| QIB | ||
| NII | 7,12,000 shares | 8,72,000 shares |
| RII | 7,12,000 shares | 8,72,000 shares |
| Employee | ||
| Others | ||
| Total | 14,24,000 shares | 17,44,000 shares |
ANG Lifesciences IPO subscribed 8.25x in total, whereas Manav infra projects IPO subscribed 2.95x.
| ANG Lifesciences IPO | Manav infra projects IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 5.13x | 0.57x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 11.36x | 5.33x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 8.25x | 2.95x |
